Table of contents

May 2008 Volume 5 No 5

Top

Editorial

Screening, stem cells, biomarkers and hypercholesterolemia: our first original clinical research

Valentin Fuster and Hannah Camm

237

doi:10.1038/ncpcardio1215 | Full Text | PDF (80K)


Top

Viewpoint

Are diuretics overused in the treatment of chronic heart failure?

Amalia Vaz Pérez, Stefan D Anker, Rainer Dietz and Mathias Rauchhaus

238

Diuretics are used for symptomatic treatment of chronic heart failure; however, no randomized trials have yet assessed the long-term effects of these agents on morbidity and mortality. In this article, Vaz Pérez and colleagues question the assumption that long-term diuretic therapy is beneficial and opine that the currently available data do not support the routine use of diuretics as a cornerstone of long-term medical treatment for patients with chronic heart failure.

doi:10.1038/ncpcardio1152 | Full Text | PDF (103K)


Top

Research Highlights

Statin therapy is beneficial for almost all patients with diabetes

240

doi:10.1038/ncpcardio1167 | Full Text | PDF (64K)

Patients with nephrotic syndrome have a high absolute risk of thromboembolic events

240

doi:10.1038/ncpcardio1169 | Full Text | PDF (64K)

Short-term withdrawal of warfarin carries low risk of thromboembolism

240

doi:10.1038/ncpcardio1170 | Full Text | PDF (69K)

Statin therapy reduces the risk of stroke related to inflammation following ACS

241

doi:10.1038/ncpcardio1171 | Full Text | PDF (64K)

Predictors of long-term outcome after tetralogy of Fallot repair

241

doi:10.1038/ncpcardio1173 | Full Text | PDF (71K)

Polymorphism in KIF6 associated with coronary events in two independent cohorts

242

doi:10.1038/ncpcardio1174 | Full Text | PDF (66K)

Impaired perfusion after MI is associated with ventricular tachycardia and fibrillation

242

doi:10.1038/ncpcardio1175 | Full Text | PDF (66K)

In-hospital VTE risk—many patients do not receive appropriate prophylaxis

243

doi:10.1038/ncpcardio1177 | Full Text | PDF (61K)

Certain definitions of metabolic syndrome might better predict new vascular events

243

doi:10.1038/ncpcardio1178 | Full Text | PDF (61K)


Top

Practice Points

Are thiazolidinediones associated with an increased risk of heart failure and cardiovascular death?

Paresh Dandona and Ajay Chaudhuri

244

doi:10.1038/ncpcardio1121 | Full Text | PDF (104K)

Is carotid angioplasty followed by cardiac surgery a safe and effective treatment for carotid artery stenosis?

Peter RF Bell

246

doi:10.1038/ncpcardio1162 | Full Text | PDF (101K)

Ranolazine: a new antiarrhythmic agent for patients with non-ST-segment elevation acute coronary syndromes?

Charles Antzelevitch

248

doi:10.1038/ncpcardio1153 | Full Text | PDF (102K)

Palliative care for patients with acute decompensated heart failure: an underused service?

David B Bekelman and Edward P Havranek

250

doi:10.1038/ncpcardio1154 | Full Text | PDF (101K)

Is prasugrel superior to clopidogrel for patients with acute coronary syndromes undergoing PCI?

Deepak L Bhatt

252

doi:10.1038/ncpcardio1164 | Full Text | PDF (102K)

The importance of EXPRESS treatment for transient ischemic attack

Pierre Amarenco

254

doi:10.1038/ncpcardio1155 | Full Text | PDF (99K)

Does parental premature cardiovascular disease predict arterial calcification in offspring?

Ulf de Faire

256

doi:10.1038/ncpcardio1147 | Full Text | PDF (100K)


Top

Reviews

Continuing Medical Education

Mechanisms of Disease: molecular genetics of arrhythmogenic right ventricular dysplasia/cardiomyopathy

Mark M Awad, Hugh Calkins and Daniel P Judge

258

Here, Mark Awad, Hugh Calkins and Daniel Judge tackle the known genetic mutations associated with arrhythmogenic right ventricular dysplasia/cardiomyopathy, and examine the complex issues surrounding genetic analysis in the clinical assessment of individuals with this condition.

doi:10.1038/ncpcardio1182 | Full Text | PDF (246K)

Aortic regurgitation: disease progression and management

Seth H Goldbarg and Jonathan L Halperin

269

The development of aortic regurgitation is often insidious and rate of disease progression varies between individuals. As such, symptoms do not necessarily correlate with objective evidence of ventricular dysfunction and the most appropriate criteria for risk stratification and optimum medical therapy remain controversial. Here the epidemiology of AR and evolution of practice guidelines regarding diagnosis and treatment are examined.

doi:10.1038/ncpcardio1179 | Full Text | PDF (235K)

Measurement of carotid intima–media thickness to assess progression and regression of atherosclerosis

Eric de Groot, Sander I van Leuven, Raphaël Duivenvoorden, Marijn C Meuwese, Fatima Akdim, Michiel L Bots and John JP Kastelein

280

Atherosclerosis can remain below the clinical horizon for a long time. Acute vascular disease, however, can manifest clinically at almost any stage. Brightness ultrasonographic imaging of the carotid arterial walls can depict all stages of atherosclerotic arterial wall changes as a continuous variable. Here de Groot et al. describe the role of carotid IMT measurements as a tool in risk evaluation of individuals and explore how this technique could advance atherosclerosis research.

doi:10.1038/ncpcardio1163 | Full Text | PDF (278K)


Top

Case Study

Continuing Medical Education

Catheter ablation of premature ventricular contraction-induced cardiomyopathy

Vivienne A Ezzat, Reginald Liew and David E Ward

289

Premature ventricular complexes are a common form of arrhythmia and are typically considered to be benign. In this month's Case Study, however, Ezzat and colleagues present a patient with dilated cardiomyopathy which was postulated to be caused by premature ventricular complexes arising from the right ventricular outflow tract. She was successfully treated by electrophysiological mapping and cryoablation of the ectopic focus.

doi:10.1038/ncpcardio1180 | Full Text | PDF (306K)


Extra navigation

.

ADVERTISEMENT